MEMBERS AREA
Do not risk more than 5% of your trading account on any one trade but do try to take ALL of the trades. Please remember, ALL “Exit Targets” and “Stop Targets” are targets. You should not have any “Hard Stops” entered to close any tradesor “Exit Orders” in your brokerage account unless we list one. We will send out a “Profit Alert” or “New Trade” if we want you to close a position OR if a new trade comes out. Otherwise, follow instructions at all times in the 9am and 1pm updates. Also, we will usually give you a heads-up if we think we are going to send an email outside of these time frames. Closed Trades for 2013: 133-79 – the Weekly Wrap is 41-5 for 2013 (85-7 since 2011) and is designed for traders that want to use options with less risk.
Cliff’s Natural Resources (CLF, $26.49, up $1.48)
January 26 calls (CLF140118C00026000, $1.45, up $0.75)
Entry Price: $0.65 (12/24/13)
Exit Target: $1.30
Return: 125%
Stop Target: None
Action: Close a THIRD of the trade at current levels.
PowerShares QQQ (QQQ, $87.56, down $0.18)
January 89 calls (QQQ140118C00089000, $0.42, down $0.06)
Entry Price: $0.40 (12/24/13)
Exit Target: $0.80
Return: 5%
Stop Target: None
Action: We are penciling-in a possible run to $90 with support back at $85.
Exact Sciences (EXAS, $12.22, flat)
January 13 calls (EXAS140118C00013000, $0.45, flat)
Entry Price: $0.45 (12/24/13)
Exit Target: $0.90
Return: 0%
Stop Target: None
Action: Shares continue to hold their uptrend line with support at $11.75. There is risk down to $11.50-$11.25 on a break below this level. A pop past $12.25-$12.50 would be bullish and could lead to a run to the mid-teens.
Herbalife (HLF, $78.26, down $0.51)
January 82.50 calls (weekly)(HLF140103C00082500, $0.60, down $0.10)
Entry Price: $1.70 (12/17/13)
Exit Target: $3.80
Return: -64%
Stop Target: None
Action: We would like to see a close back above $80 today. We have said we would stick with the trade as long as $75 holds. This has been a whipsawed stock all year and with these being weekly options that expire next week, we may have to cut the cord if there is no rebound by next Tuesday.
Vera Bradley (VRA, $23.90, up $0.15)
January 22.50 puts (VRA140118P00022500, $0.40, down $0.05)
Entry Price: $1.20 (12/10/13)
Exit Target: $2.40
Return: -67%
Stop Target: None
Action: There is risk up to $24. We are expecting a drop to $21-$20.50 by mid-January and would like to see shares drift back towards $22.50 by next Tuesday. We will like exit the trade on a print above $24 again.
Ariad Pharmaceuticals (ARIA, $6.68, down $0.32)
January 7 calls (ARIA130118C00007000, $0.50, down $0.20)
Entry Price: $0.45 (12/3/13)
Exit Target: $0.90-$1.35 (closed a quarter @ $0.90 on 12/20/13)
Return: 55%
Stop Target: 45 cents
Action: On a technical level, there is a gap to fill from $6 to $18.
Pulte Group (PHM, $20.15, up $0.17)
January 20 calls (PHM140118C00020000, $0.70, up $0.05)
Entry Price: $0.50 (11/27/13)
Exit Target: $1.00 (closed a third @ $0.75 on 12/26/13)
Return: 41%
Stop Target: None
Action: A close above $20 should get $22 in play. Yesterday’s high was $$20.32 and the 52-week peak is north of $24. We will need $19.25 to hold as support on any pullback to keep us in the trade.
Opko Health (OPK, $8.60, down $0.20)
January 11 calls (OPK140118C00011000, $0.10, flat)
Entry Price: $0.65 (11/26/13)
Exit Target: $1.30
Return: -67%
Stop Target: None
Action: A close above $9.50 would be bullish. Support is at $8.50 with risk down to $8.
Galena Biopharma (GALE, $4.33, up $0.26)
January 2.50 calls (GALE140118C00002500, $1.60, up $0.10)
Entry Price: $0.30 (11/11/13)
Exit Target: $0.90 (closed a quarter @ $1 on 11/21/13, closed a quarter @ $1.50 on 12/10/13)
Return: 375%
Stop Target: $1 on remaining half position (Stop Limit)
Action: Our stop limit is at $1 and will take us out of the trade if shares fall below $3.50. We are still looking for a run past $5 and a close above $4.20 would be bullish.
Other 2013 Portfolio OPEN positions (0): These are trades that are still open in the portfolio but are down over 50%. They have longer expiration dates and are on “hold” but are not worth mentioning until they turn around. This means we would not open any new positions. We are still keeping track of the trades and we will record the results, accordingly, when we close them or if the options expire. Click on the 2013Portfolio link in the Members Area to view ALL open/ closed trades.
WATCH LIST SECTION
These trades are NOT recommendations. They are trades that we like but have not added to the portfolio as an official recommendation because of market conditions or because we are waiting for better entry prices. We try not to have more than 12-15 open trades at any one time which is why we created a Watch List. We will not list entry prices because these stocks are on the verge of breaking out or they could sell off but these are the trades we are watching as new candidates.
MEMBERS AREA
Do not risk more than 5% of your trading account on any one trade but do try to take ALL of the trades. Please remember, ALL “Exit Targets” and “Stop Targets” are targets. You should not have any “Hard Stops” entered to close any tradesor “Exit Orders” in your brokerage account unless we list one. We will send out a “Profit Alert” or “New Trade” if we want you to close a position OR if a new trade comes out. Otherwise, follow instructions at all times in the 9am and 1pm updates. Also, we will usually give you a heads-up if we think we are going to send an email outside of these time frames. Closed Trades for 2013: 133-79 – the Weekly Wrap is 41-5 for 2013 (85-7 since 2011) and is designed for traders that want to use options with less risk.
Cliff’s Natural Resources (CLF, $26.49, up $1.48)
January 26 calls (CLF140118C00026000, $1.45, up $0.75)
Entry Price: $0.65 (12/24/13)
Exit Target: $1.30
Return: 125%
Stop Target: None
Action: Close a THIRD of the trade at current levels.
PowerShares QQQ (QQQ, $87.56, down $0.18)
January 89 calls (QQQ140118C00089000, $0.42, down $0.06)
Entry Price: $0.40 (12/24/13)
Exit Target: $0.80
Return: 5%
Stop Target: None
Action: We are penciling-in a possible run to $90 with support back at $85.
Exact Sciences (EXAS, $12.22, flat)
January 13 calls (EXAS140118C00013000, $0.45, flat)
Entry Price: $0.45 (12/24/13)
Exit Target: $0.90
Return: 0%
Stop Target: None
Action: Shares continue to hold their uptrend line with support at $11.75. There is risk down to $11.50-$11.25 on a break below this level. A pop past $12.25-$12.50 would be bullish and could lead to a run to the mid-teens.
Herbalife (HLF, $78.26, down $0.51)
January 82.50 calls (weekly)(HLF140103C00082500, $0.60, down $0.10)
Entry Price: $1.70 (12/17/13)
Exit Target: $3.80
Return: -64%
Stop Target: None
Action: We would like to see a close back above $80 today. We have said we would stick with the trade as long as $75 holds. This has been a whipsawed stock all year and with these being weekly options that expire next week, we may have to cut the cord if there is no rebound by next Tuesday.
Vera Bradley (VRA, $23.90, up $0.15)
January 22.50 puts (VRA140118P00022500, $0.40, down $0.05)
Entry Price: $1.20 (12/10/13)
Exit Target: $2.40
Return: -67%
Stop Target: None
Action: There is risk up to $24. We are expecting a drop to $21-$20.50 by mid-January and would like to see shares drift back towards $22.50 by next Tuesday. We will like exit the trade on a print above $24 again.
Ariad Pharmaceuticals (ARIA, $6.68, down $0.32)
January 7 calls (ARIA130118C00007000, $0.50, down $0.20)
Entry Price: $0.45 (12/3/13)
Exit Target: $0.90-$1.35 (closed a quarter @ $0.90 on 12/20/13)
Return: 55%
Stop Target: 45 cents
Action: On a technical level, there is a gap to fill from $6 to $18.
Pulte Group (PHM, $20.15, up $0.17)
January 20 calls (PHM140118C00020000, $0.70, up $0.05)
Entry Price: $0.50 (11/27/13)
Exit Target: $1.00 (closed a third @ $0.75 on 12/26/13)
Return: 41%
Stop Target: None
Action: A close above $20 should get $22 in play. Yesterday’s high was $$20.32 and the 52-week peak is north of $24. We will need $19.25 to hold as support on any pullback to keep us in the trade.
Opko Health (OPK, $8.60, down $0.20)
January 11 calls (OPK140118C00011000, $0.10, flat)
Entry Price: $0.65 (11/26/13)
Exit Target: $1.30
Return: -67%
Stop Target: None
Action: A close above $9.50 would be bullish. Support is at $8.50 with risk down to $8.
Galena Biopharma (GALE, $4.33, up $0.26)
January 2.50 calls (GALE140118C00002500, $1.60, up $0.10)
Entry Price: $0.30 (11/11/13)
Exit Target: $0.90 (closed a quarter @ $1 on 11/21/13, closed a quarter @ $1.50 on 12/10/13)
Return: 375%
Stop Target: $1 on remaining half position (Stop Limit)
Action: Our stop limit is at $1 and will take us out of the trade if shares fall below $3.50. We are still looking for a run past $5 and a close above $4.20 would be bullish.
Other 2013 Portfolio OPEN positions (0): These are trades that are still open in the portfolio but are down over 50%. They have longer expiration dates and are on “hold” but are not worth mentioning until they turn around. This means we would not open any new positions. We are still keeping track of the trades and we will record the results, accordingly, when we close them or if the options expire. Click on the 2013Portfolio link in the Members Area to view ALL open/ closed trades.
WATCH LIST SECTION
These trades are NOT recommendations. They are trades that we like but have not added to the portfolio as an official recommendation because of market conditions or because we are waiting for better entry prices. We try not to have more than 12-15 open trades at any one time which is why we created a Watch List. We will not list entry prices because these stocks are on the verge of breaking out or they could sell off but these are the trades we are watching as new candidates.
We will update this section on Monday.
MEMBERS AREA
9:00 am
Do not risk more than 5% of your trading account on any one trade but do try to take ALL of the trades. Please remember, ALL “Exit Targets” and “Stop Targets” are targets. You should not have any “Hard Stops” entered to close any tradesor “Exit Orders” in your brokerage account unless we list one. We will send out a “Profit Alert” or “New Trade” if we want you to close a position OR if a new trade comes out. Otherwise, follow instructions at all times in the 9am and 1pm updates. Also, we will usually give you a heads-up if we think we are going to send an email outside of these time frames. Closed Trades for 2013: 133-79 – the Weekly Wrap is 41-5 for 2013 (85-7 since 2011) and is designed for traders that want to use options with less risk.
Cliff’s Natural Resources (CLF, $25.01, up $0.25)
January 26 calls (CLF140118C00026000, $0.70, up $0.05)
Entry Price: $0.65 (12/24/13)
Exit Target: $1.30
Return: 8%
Stop Target: None
Action: Shares traded to a high of $25.32 but missed our $25.25 close we are looking for ahead of the weekend. A close above this level could lead to a run to $27-$28 over the near-term. Support is at $24.
PowerShares QQQ (QQQ, $87.74, up $0.29)
January 89 calls (QQQ140118C00089000, $0.48, up $0.06)
Entry Price: $0.40 (12/24/13)
Exit Target: $0.80
Return: 20%
Stop Target: None
Action: We are penciling-in a possible run to $90 with support back at $85.
Exact Sciences (EXAS, $12.22, down $0.23)
January 13 calls (EXAS140118C00013000, $0.45, flat)
Entry Price: $0.45 (12/24/13)
Exit Target: $0.90
Return: 0%
Stop Target: None
Action: Shares continue to hold their uptrend line with support at $11.75. There is risk down to $11.50-$11.25 on a break below this level. A pop past $12.25-$12.50 would be bullish and could lead to a run to the mid-teens.
Herbalife (HLF, $78.77, up $0.22)
January 82.50 calls (weekly)(HLF140103C00082500, $0.70, down $0.20)
Entry Price: $1.70 (12/17/13)
Exit Target: $3.80
Return: -59%
Stop Target: None
Action: We would like to see a close back above $80 today. We have said we would stick with the trade as long as $75 holds. This has been a whipsawed stock all year and with these being weekly options that expire next week, we may have to cut the cord if there is no rebound by next Tuesday.
Vera Bradley (VRA, $23.75, up $0.26)
January 22.50 puts (VRA140118P00022500, $0.45, down $0.10)
Entry Price: $1.20 (12/10/13)
Exit Target: $2.40
Return: -65%
Stop Target: None
Action: There is risk up to $24. We are expecting a drop to $21-$20.50 by mid-January and would like to see shares drift back towards $22.50 by next Tuesday. We will like exit the trade on a print above $24 again.
Ariad Pharmaceuticals (ARIA, $7.00, down $0.11)
January 7 calls (ARIA130118C00007000, $0.70, down $0.10)
Entry Price: $0.45 (12/3/13)
Exit Target: $0.90-$1.35 (closed a quarter @ $0.90 on 12/20/13)
Return: 75%
Stop Target: 45 cents
Action: On a technical level, there is a gap to fill from $6 to $18.
Pulte Group (PHM, $19.98, up $0.25)
January 20 calls (PHM140118C00020000, $0.65, up $0.10)
Entry Price: $0.50 (11/27/13)
Exit Target: $1.00 (closed a third @ $0.75 on 12/26/13)
Return: 41%
Stop Target: None
Action: We wanted to close some of the trade into strength yesterday. A close above $20 should get $22 in play. Yesterday’s high was $$20.32 and the 52-week peak is north of $24. We will need $19.25 to hold as support on any pullback to keep us in the trade.
Opko Health (OPK, $8.80 down $0.24)
January 11 calls (OPK140118C00011000, $0.10, down $0.10)
Entry Price: $0.65 (11/26/13)
Exit Target: $1.30
Return: -67%
Stop Target: None
Action: A close above $9.50 would be bullish. Support is at $8.50 with risk down to $8.
Galena Biopharma (GALE, $4.07, up $0.07)
January 2.50 calls (GALE140118C00002500, $1.50, flat)
Entry Price: $0.30 (11/11/13)
Exit Target: $0.90 (closed a quarter @ $1 on 11/21/13, closed a quarter @ $1.50 on 12/10/13)
Return: 358%
Stop Target: $1 on remaining half position (Stop Limit)
Action: Our stop limit is at $1 and will take us out of the trade if shares fall below $3.50. We are still looking for a run past $5 and a close above $4.20 would be bullish.
Other 2013 Portfolio OPEN positions (0): These are trades that are still open in the portfolio but are down over 50%. They have longer expiration dates and are on “hold” but are not worth mentioning until they turn around. This means we would not open any new positions. We are still keeping track of the trades and we will record the results, accordingly, when we close them or if the options expire. Click on the 2013Portfolio link in the Members Area to view ALL open/ closed trades.
WATCH LIST SECTION
These trades are NOT recommendations. They are trades that we like but have not added to the portfolio as an official recommendation because of market conditions or because we are waiting for better entry prices. We try not to have more than 12-15 open trades at any one time which is why we created a Watch List. We will not list entry prices because these stocks are on the verge of breaking out or they could sell off but these are the trades we are watching as new candidates.
Osiris Therapeutics (OSIR, $16.28, down $0.14)
January 18 calls (OSIR140118C00018000, $0.40, flat)
February 20 calls (OSIR140222C00020000, $0.65, flat)
Thoughts: We will have to use strict limit orders to get into this trade as the bid/ask is a little wide. We are expecting a run past $20 over the near-term.
Morgan Stanley (MS, $31.10, up $0.09)
January 32 calls (MS140118C00032000, $0.45, flat)
Thoughts: Resistance is at $31.50. Support is at $30.
Twitter (TWTR, $73.31, up $3.35)
January 60 calls (TWTR140118C00060000, $14.50, up $3.75)
January 49 puts (TWTR140118P00049000, $0.30, up $0.10)
Thoughts: Support is at $65. A run past $80 now appears to be in the works.
Gold Shares (GLD, $116.74, up $0.64)
January 115 puts (GLD140118P00115000, $1.60, down $0.20)
Thoughts: We knew the breakdown was coming and we should have positioned ourselves for the move. We would love to see a back test to $120 but $115 may be all we get before a drop to $110.
iShares Russell 2000 (IWM, $115.23, up $0.01)
January 117 calls (IWM140118C00117000, $0.80, down $0.05)
January 110 puts (IWM140118P00110000, $0.40,flat)
Thoughts: We could go short on a close below $112.50 or long on a pop past $115. At current levels the options together might make a good strangle trade.
International Business Machines (IBM, $185.35, up $2.13)
January 180 puts (IBM140118P00180000, $0.90, down $0.45)
Thoughts: We should have added calls on IBM’s recent strength but we don’t trust Big Blue right now. We will get a chance to short this stock at some point.